Pharmatrack Information

Pharmatrack was established in 2005 after identifying an unfulfilled intelligence gap / requirement in the market. Pharmaceutical companies' preferred modus of operandi is to manage their product portfolio within the supply market themselves as opposed to using a third party. This means they have a need for independent (*) and unbiased commercial intelligence to assist with the crucial decisions they have to make on a regular basis. Pharmaceutical companies are continually facing downward pressure as their strategic commercial models have been propelled into the limelight with greater efficiencies being sought. They face increasing competition from generic products, as by 2012 less than 40% of products worldwide will be protected by a patent, movement around the EU becomes more competitive as all the different entities in the European supply market compete for margin and pharmacies continually chase revenue. The legitimate supply market is a competitive arena where product (European, brand, generic) have a major common denominator; they are all margin sensitive. Pharmatrack(*) has established a network of innovative specialist supply market contacts and is positioned uniquely with a thorough understanding and interpretation of both the supply market and pharmaceutical companies' strategic drivers and requirements, enabling them to be transposed, to offer a UNIQUE and INDEPENDENT (*) service to pharmaceutical companies. (*) Pharmatrack has decades of experience working with pharmaceutical companies and is not a trader and does not hold a wholesaler's dealer's licence.